Jennifer Lew
CIK: 0001465994
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 15, 2026BOLD
Boundless Bio, Inc.
Award(A)DirectStock Option (right to buy)
32K shares- - Mar 2, 2026ANNX
Annexon, Inc.
Sale(S)Direct5.6K shares at avg. $5.42$30K - Feb 19, 2026ANNX
Annexon, Inc.
Award(A)Direct62.5K shares- - Feb 18, 2026ANNX
Annexon, Inc.
Sale(S)Direct7.9K shares at avg. $5.11$40K - Jul 14, 2025ANNX
Annexon, Inc.
Sale(S)Direct1.1K shares at avg. $2.58$3K - Jun 23, 2025BOLD
Boundless Bio, Inc.
Award(A)DirectStock Option (right to buy)
16K shares- - Feb 27, 2025ANNX
Annexon, Inc.
Award(A)DirectStock Option (Right to Buy)
272.6K shares- - Feb 18, 2025ANNX
Annexon, Inc.
Sale(S)Direct6.9K shares at avg. $2.92$20K - Feb 13, 2025ANNX
Annexon, Inc.
Sale(S)Direct1.8K shares at avg. $2.98$5K - Feb 27, 2024ANNX
Annexon, Inc.
Award(A)Direct45K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  BOLD Boundless Bio, Inc. | Award(A) Stock Option (right to buy) | 32,000 | - | - | Direct |
| Mar 2, 2026 |  ANNX Annexon, Inc. | Sale(S) | 5,565 | $5.42 | $30,162 | Direct |
| Feb 19, 2026 | ANNX Annexon, Inc. | Award(A) | 62,500 | - | $0 | Direct |
| Feb 18, 2026 | ANNX Annexon, Inc. | Sale(S) | 7,851 | $5.11 | $40,119 | Direct |
| Jul 14, 2025 | ANNX Annexon, Inc. | Sale(S) | 1,117 | $2.58 | $2,882 | Direct |
| Jun 23, 2025 | BOLD Boundless Bio, Inc. | Award(A) Stock Option (right to buy) | 16,000 | - | - | Direct |
| Feb 27, 2025 | ANNX Annexon, Inc. | Award(A) Stock Option (Right to Buy) | 272,575 | - | - | Direct |
| Feb 18, 2025 | ANNX Annexon, Inc. | Sale(S) | 6,912 | $2.92 | $20,183 | Direct |
| Feb 13, 2025 | ANNX Annexon, Inc. | Sale(S) | 1,786 | $2.98 | $5,322 | Direct |
| Feb 27, 2024 | ANNX Annexon, Inc. | Award(A) | 44,963 | - | - | Direct |
1-10 of 10 transactions
About Lew Jennifer
Lew Jennifer (SEC CIK 0001465994) files insider reports with the SEC as Director of Boundless Bio, Inc. (BOLD) and EVP & CHIEF FINANCIAL OFFICER of Annexon, Inc. (ANNX).
Signal8 holds 9 ownership filings by Lew Jennifer, all Form 4s, filed between Feb 18, 2025 and Jun 15, 2026. Those filings report 10 transactions, from Feb 27, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lew Jennifer's filings is in LA JOLLA, CA.
Recent filings by Lew Jennifer
- Jun 15, 2026: Grant or award of BOLD derivative securities (Form 4, code A).
- Mar 2, 2026: Open-market sale of ANNX shares (Form 4, code S).
- Feb 19, 2026: Grant or award of ANNX shares (Form 4, code A).
- Feb 18, 2026: Open-market sale of ANNX shares (Form 4, code S).
- Jul 14, 2025: Open-market sale of ANNX shares (Form 4, code S).
Other insiders filing for Boundless Bio, Inc. (BOLD)
- TANG KEVIN, 10% Owner
- CRANDELL KEITH, 10% Owner
- ARCH Venture Fund IX, L.P., 10% Owner
- Whiting Nancy, Director
- Lim Jonathan E, Director
- Christensen James, Director